Abstract
1 The plasma levels of propranolol and 4-hydroxypropranolol have been measured in 17 hypertensive patients receiving chronic oral therapy with propranolol. 2 The range of plasma propranolol concentrations was from 5.3 to 300 ng/ml, and that of 4-hydroxypropranolol was from 2.1 to 36.0 ng/ml. 3 The mean (+/- s.d.) plasma concentration ratio of 4-hydroxypropranolol to propranolol was 0.130 (+/- 0.005); however, a very wide range was observed with individual values ranging from 0.057 to 0.241. 4 A statistically significant correlation was observed between the plasma concentration of 4-hydroxypropranolol and that of propranolol. 5 Propranolol and 4-hydroxypropranolol plasma concentrations were each significantly, but poorly, correlated with daily propranolol dose. 6 The clinical significance of the results has been discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chidsey C. A., Morselli P., Bianchetti G., Morganti A., Leonetti G., Zanchetti A. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation. 1975 Aug;52(2):313–318. doi: 10.1161/01.cir.52.2.313. [DOI] [PubMed] [Google Scholar]
- Cleaveland C. R., Shand D. G. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181–185. doi: 10.1002/cpt1972132181. [DOI] [PubMed] [Google Scholar]
- Cotham R. H., Shand D. Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):535–538. doi: 10.1002/cpt1975185part1535. [DOI] [PubMed] [Google Scholar]
- Fitzgerald J. D., O'Donnell S. R. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Br J Pharmacol. 1971 Sep;43(1):222–235. doi: 10.1111/j.1476-5381.1971.tb07171.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garceau Y., Davis I., Hasegawa J. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine. J Pharm Sci. 1978 Jun;67(6):826–831. doi: 10.1002/jps.2600670626. [DOI] [PubMed] [Google Scholar]
- Hayes A., Cooper R. G. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. J Pharmacol Exp Ther. 1971 Feb;176(2):302–311. [PubMed] [Google Scholar]
- Johnsson G., Regàrdh C. G. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs. Clin Pharmacokinet. 1976;1(4):233–263. doi: 10.2165/00003088-197601040-00001. [DOI] [PubMed] [Google Scholar]
- McDevitt D. G., Frisk-Holmberg M., Hollifield J. W., Shand D. G. Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther. 1976 Aug;20(2):152–157. doi: 10.1002/cpt1976202152. [DOI] [PubMed] [Google Scholar]
- Nation R. L., Peng G. W., Chiou W. L. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma. J Chromatogr. 1978 May 1;145(3):429–436. doi: 10.1016/s0378-4347(00)81372-9. [DOI] [PubMed] [Google Scholar]
- Nies A. S., Shand D. G. Clinical pharmacology of propranolol. Circulation. 1975 Jul;52(1):6–15. doi: 10.1161/01.cir.52.1.6. [DOI] [PubMed] [Google Scholar]
- Walle T., Morrison J., Walle K., Conradi E. Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography. J Chromatogr. 1975 Nov 26;114(2):351–359. doi: 10.1016/s0021-9673(01)92000-x. [DOI] [PubMed] [Google Scholar]
- Zacest R., Koch-Weser J. Relation of propranolol plasma level to beta-blockade during oral therapy. Pharmacology. 1972;7(3):178–184. doi: 10.1159/000136287. [DOI] [PubMed] [Google Scholar]